PACIRA BIOSCIENCES, INC. Payments to Acquire Investments
PACIRA BIOSCIENCES, INC. (PCRX) reported Payments to Acquire Investments of $1.22 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-04.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2021-05-04
- PACIRA BIOSCIENCES, INC. payments to acquire investments for the quarter ending 2021-03-31 was $1.22M.
- PACIRA BIOSCIENCES, INC. payments to acquire investments for the quarter ending 2020-03-31 was $0.00.
- PACIRA BIOSCIENCES, INC. payments to acquire investments for the quarter ending 2014-12-31 was $164.30M.
- PACIRA BIOSCIENCES, INC. payments to acquire investments for fiscal 2020 was $546.52M, a 71.60% increase from fiscal 2019.
- PACIRA BIOSCIENCES, INC. payments to acquire investments for fiscal 2019 was $318.48M, a 12.32% decline from fiscal 2018.
- PACIRA BIOSCIENCES, INC. payments to acquire investments for fiscal 2018 was $363.25M, a 27.75% decline from fiscal 2017.
- PACIRA BIOSCIENCES, INC. payments to acquire investments for fiscal 2017 was $502.75M, a 160.74% increase from fiscal 2016.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 12 month |
|---|---|---|
| 2021-03-31 | $1.22M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $546.52M 10-K · filed 2021-03-01 | |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-04 | |
| 2019-12-31 | $318.48M 10-K · filed 2021-03-01 | |
| 2018-12-31 | $363.25M 10-K · filed 2021-03-01 | |
| 2017-12-31 | $502.75M 10-K · filed 2020-02-21 | |
| 2016-12-31 | $192.81M 10-K · filed 2019-02-28 | |
| 2015-12-31 | $189.08M 10-K · filed 2018-02-28 | |
| 2014-12-31 | $164.30M 10-K · filed 2017-03-01 | $164.30M 10-K · filed 2016-02-25 |
| 2013-12-31 | $114.30M 10-K · filed 2016-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |